Drugs / DDP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06364384 Background | Apr 2024 → Sep 2026 overdue | squamous cell carcinoma of rectum | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDP | “a)DDP 75 mg/m2, d1, intravenous infusion” NCT06364384 ↗ |
| Route | Intravenous | “DDP 75 mg/m2, d1, intravenous infusion” NCT06364384 ↗ |